Welcome to Kidney Cancer Journal

Volume 4, Number 4 Winter 2006-2007

Interview with Naomi B. Haas, MD
A New Adjuvant Trial Is Born: E2805 to Study Effects
of Sorafenib, Sunitinib After Nephrectomy

New Biomarker Offers Prognostic Potential for Risk of Metastasis in Renal Cell Carcinoma
Zhong Jiang, MD

Vertical Combination Therapy to Block the VEGF Pathway:
Rationale for Targeting Both Ligand and Receptor
Keith Flaherty, MD

Pharmacological Modulation of Tumor Blood Flow Enhances Efficacy of Radiofrequency Ablation in Renal Cell Carcinoma
S. Nahum Goldberg, MD

Challenging Cases in Kidney Cancer

To view this issue, click here.

Volume 4, Number 3 Autumn 2006

Signal Transduction Pathways in RCC: Exploring the
Essential Role of mTOR as a Target for Therapy
Gary R. Hudes, MD

Therapy Targeted at Vascular Endothelial Growth Factor:
Treating Ligand Is Different from Treating Receptor
Keith Flaherty, MD

Management of Hypertension Associated with
Antiangiogenesis Therapy
Domenic A. Sica, MD

Special Considerations and Guidelines for Screening Dialysis Patients for RCC Before Transplantation
Hesam Farivar-Mohseni, MD

Treatment with Monoclonal Antibody cG250 (Rencarex®)
as Monotherapy or in Combination with Cytokines Prolongs Overall Survival in Metastatic RCC
Paul Bevan, PhD, Pia Kloepfer, MD, Norman Neville, MD

Challenging Cases in Kidney Cancer

To view this issue, click here.

Below are past issues of Kidney Cancer Journal. To view each issue, click on the link below the front cover. To see issues from previous years, click on the dates at the bottom of the page.

Each issue will be presented in a page-turning format, and by reading the directions to the left of the cover page, you will be able to go forward and backwards within the issue, enlarge and reduce pages, view the table of contents in the upper left, conduct a search of the entire issue

Volume 4, Number 2 Summer 2006

Guest Editorial: Physicians, Patients, Industry, and Regulators:An Unholy but Necessary Alliance for Cancer Clinical Trials
Walter Stadler, MD Bill Bro

Long-Term Bevacizumab Therapy in Metastatic Renal Cell Carcinoma
Brian I. Rini, MD

Kidney Cancer Highlights from AUA 2006
Advances in Minimally Invasive Surgery, Novel Molecular Markers, and New Prognostication Models Suggest Future Directions
Allan J. Pantuck, MD

Kidney Cancer Highlights from ASCO 2006
Latest Findings on Anti-VEGF Strategies Highlight
Response Rates, Improvements in Progression-Free Survival
Ronald Bukowski, MD

ASCO 2006 Highlights: Perspectives on the Plenary Session
Banner Day in Kidney Cancer Ushers in New Treatment Algorithm and Points to Investigative Challenges

Challenging Cases in Kidney Cancer

To view this issue, click here.

Volume 4, Number 1 Spring 2006

Histologic Predictors of Renal Cell Carcinoma Response to
Interleukin-2: New Model of Patient Selection
Melissa P. Upton, MD

Multilocular Cystic Renal Cell Carcinoma: Identifying the
Optimal Paradigm for Diagnosis and Treatment
Xavier Leroy, MD, PhD

Point-Counterpoint
Should Strategies for Cytoreductive Nephrectomy
Change in the New Era of Targeted Therapy?

Integrating the Oncology Nurse Into the New Paradigm of Targeted Therapy in Renal Cell Cancer: Special Considerations, Initiatives, and Guidelines
Nancy Moldawer, RN, MSN and Laura S. Wood, RN, MSN, OCN

Challenging Cases in Kidney Cancer

To view this issue, click here.

by entering a key word in the upper right field, and print individual pages. Please note that slower internet connections will cause the pages to open, turn, and enlarge more slowly.

When you see an active hyperlink within the general text, an article (not the references) or in an ad unit, you can click that link to send an e-mail or be taken to that web page.